Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis

M. Ghashghaeinia, P. Koralkova, D. Giustarini, R. Mojzikova, B. Fehrenbacher, P. Dreischer, M. Schaller, U. Mrowietz, A. Martínez-Ruiz, T. Wieder, V. Divoky, R. Rossi, F. Lang, M. Köberle

. 2020 ; 25 (9-10) : 674-685. [pub] -

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026498
E-zdroje Online Plný text

NLK ProQuest Central od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-02-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do Před 1 rokem

Costunolide, a natural sesquiterpene lactone, has multiple pharmacological activities such as neuroprotection or induction of apoptosis and eryptosis. However, the effects of costunolide on pro-survival factors and enzymes in human erythrocytes, e.g. glutathione and glucose-6-phosphate dehydrogenase (G6PDH) respectively, have not been studied yet. Our aim was to determine the mechanisms underlying costunolide-induced eryptosis and to reverse this process. Phosphatidylserine exposure was estimated from annexin-V-binding, cell volume from forward scatter in flow cytometry, and intracellular glutathione [GSH]i from high performance liquid chromatography. The oxidized status of intracellular glutathione and enzyme activities were measured by spectrophotometry. Treatment of erythrocytes with costunolide dose-dependently enhanced the percentage of annexin-V-binding cells, decreased the cell volume, depleted [GSH]i and completely inhibited G6PDH activity. The effects of costunolide on annexin-V-binding and cell volume were significantly reversed by pre-treatment of erythrocytes with the specific PKC-α inhibitor chelerythrine. The latter, however, had no effect on costunolide-induced GSH depletion. Costunolide induces eryptosis, depletes [GSH]i and inactivates G6PDH activity. Furthermore, our study reveals an inhibitory effect of chelerythrine on costunolide-induced eryptosis, indicating a relationship between costunolide and PKC-α. In addition, chelerythrine acts independently of the GSH depletion. Understanding the mechanisms of G6PDH inhibition accompanied by GSH depletion should be useful for development of anti-malarial therapeutic strategies or for synthetic lethality-based approaches to escalate oxidative stress in cancer cells for their sensitization to chemotherapy and radiotherapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026498
003      
CZ-PrNML
005      
20211026132842.0
007      
ta
008      
211013s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10495-020-01620-6 $2 doi
035    __
$a (PubMed)32638182
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Ghashghaeinia, Mehrdad $u Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Rosalind-Franklin-Str. 7, 24105, Kiel, Germany. mghashghaeinia@dermatology.uni-kiel.de $u Physiologisches Institut, Abteilung für Vegetative Und Klinische Physiologie, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany. mghashghaeinia@dermatology.uni-kiel.de
245    14
$a The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis / $c M. Ghashghaeinia, P. Koralkova, D. Giustarini, R. Mojzikova, B. Fehrenbacher, P. Dreischer, M. Schaller, U. Mrowietz, A. Martínez-Ruiz, T. Wieder, V. Divoky, R. Rossi, F. Lang, M. Köberle
520    9_
$a Costunolide, a natural sesquiterpene lactone, has multiple pharmacological activities such as neuroprotection or induction of apoptosis and eryptosis. However, the effects of costunolide on pro-survival factors and enzymes in human erythrocytes, e.g. glutathione and glucose-6-phosphate dehydrogenase (G6PDH) respectively, have not been studied yet. Our aim was to determine the mechanisms underlying costunolide-induced eryptosis and to reverse this process. Phosphatidylserine exposure was estimated from annexin-V-binding, cell volume from forward scatter in flow cytometry, and intracellular glutathione [GSH]i from high performance liquid chromatography. The oxidized status of intracellular glutathione and enzyme activities were measured by spectrophotometry. Treatment of erythrocytes with costunolide dose-dependently enhanced the percentage of annexin-V-binding cells, decreased the cell volume, depleted [GSH]i and completely inhibited G6PDH activity. The effects of costunolide on annexin-V-binding and cell volume were significantly reversed by pre-treatment of erythrocytes with the specific PKC-α inhibitor chelerythrine. The latter, however, had no effect on costunolide-induced GSH depletion. Costunolide induces eryptosis, depletes [GSH]i and inactivates G6PDH activity. Furthermore, our study reveals an inhibitory effect of chelerythrine on costunolide-induced eryptosis, indicating a relationship between costunolide and PKC-α. In addition, chelerythrine acts independently of the GSH depletion. Understanding the mechanisms of G6PDH inhibition accompanied by GSH depletion should be useful for development of anti-malarial therapeutic strategies or for synthetic lethality-based approaches to escalate oxidative stress in cancer cells for their sensitization to chemotherapy and radiotherapy.
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a benzofenantridiny $x farmakologie $7 D053119
650    _2
$a vápník $x metabolismus $7 D002118
650    _2
$a inhibitory enzymů $x farmakologie $7 D004791
650    _2
$a eryptóza $x účinky léků $x genetika $7 D000072817
650    _2
$a erytrocyty $x účinky léků $x patologie $7 D004912
650    _2
$a glukosa-6-fosfátdehydrogenasa $x antagonisté a inhibitory $x genetika $7 D005954
650    _2
$a glutathion $x genetika $7 D005978
650    _2
$a lidé $7 D006801
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    _2
$a proteinkinasa C-alfa $x antagonisté a inhibitory $x genetika $7 D051571
650    _2
$a reaktivní formy kyslíku $7 D017382
650    _2
$a seskviterpeny $x farmakologie $7 D012717
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Koralkova, Pavla $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515, Olomouc, Czech Republic
700    1_
$a Giustarini, Daniela $u Department of Biotechnology, Chemistry and Pharmacy, Laboratory of Pharmacology and Toxicology, University of Siena, Via A Moro 2, 53100, Siena, Italy
700    1_
$a Mojzikova, Renata $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515, Olomouc, Czech Republic
700    1_
$a Fehrenbacher, Birgit $u Department of Dermatology, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany
700    1_
$a Dreischer, Peter $u Physiologisches Institut, Abteilung für Vegetative Und Klinische Physiologie, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany
700    1_
$a Schaller, Martin $u Department of Dermatology, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany
700    1_
$a Mrowietz, Ulrich $u Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Rosalind-Franklin-Str. 7, 24105, Kiel, Germany
700    1_
$a Martínez-Ruiz, Antonio $u Unidad de Investigación, Hospital Santa Cristina, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain $u Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain
700    1_
$a Wieder, Thomas $u Physiologisches Institut, Abteilung für Vegetative Und Klinische Physiologie, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany $u Department of Dermatology, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany
700    1_
$a Divoky, Vladimir $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515, Olomouc, Czech Republic
700    1_
$a Rossi, Ranieri $u Department of Biotechnology, Chemistry and Pharmacy, Laboratory of Pharmacology and Toxicology, University of Siena, Via A Moro 2, 53100, Siena, Italy
700    1_
$a Lang, Florian $u Physiologisches Institut, Abteilung für Vegetative Und Klinische Physiologie, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany
700    1_
$a Köberle, Martin $u Department of Dermatology and Allergology, School of Medicine, Technical University of Munich, Biedersteinerstr. 29, 80802, München, Germany
773    0_
$w MED00007546 $t Apoptosis : an international journal on programmed cell death $x 1573-675X $g Roč. 25, č. 9-10 (2020), s. 674-685
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32638182 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132849 $b ABA008
999    __
$a ok $b bmc $g 1715273 $s 1147005
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 25 $c 9-10 $d 674-685 $e - $i 1573-675X $m Apoptosis $n Apoptosis $x MED00007546
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...